Hosted on MSN11mon
SPAC Semper Paratus shareholders okay merger with Tevogen BioSemper and Tevogen announced plans to merge in June, with the deal estimating the equity and enterprise value of the combined company at around $1.2B. More on Semper Paratus Acquisition Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback